C-reactive protein as a predictor of disease in smokers and former smokers: a review
- PMID: 19732183
- PMCID: PMC2780563
- DOI: 10.1111/j.1742-1241.2009.02179.x
C-reactive protein as a predictor of disease in smokers and former smokers: a review
Abstract
Background: Cigarette smoking is a classical and a major risk factor in the development of several diseases with an inflammatory component, including cardiovascular disease and chronic obstructive pulmonary disease. Improvements in assays for protein markers of inflammation have led to many studies on these factors and their roles in disease.
Aims: C-reactive protein (CRP) is one such marker and this review focuses on the evidence for using CRP as a diagnostic marker and how levels of this protein are modified according to the smoking status of the patient, both in terms of the current amount of cigarettes smoked and how CRP levels change following smoking cessation.
Conclusions: Assay of CRP levels may be useful in monitoring disease progression and determining risk of future cardiovascular complications. However, as this marker is also an indicator of acute inflammation and challenges to the immune system, some caution must be exercised in interpreting the available data on CRP levels in patients with different chronic comorbidities.
Figures
Comment in
-
Hot and bothered: C-reactive protein, inflammation and atherosclerosis.Int J Clin Pract. 2009 Nov;63(11):1550-3. doi: 10.1111/j.1742-1241.2009.02211.x. Int J Clin Pract. 2009. PMID: 19832810 No abstract available.
References
-
- World Health Organization . WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER Package. Geneva: World Health Organisation; 2008.
-
- Centers for Disease Control and Prevention . 2004 Surgeon General’s Report – The Health Consequences of Smoking. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004. http://www.cdc.gov/tobacco/data_statistics/sgr/sgr_2004/index.htm (accessed August 2009)
-
- Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation. 1997;96:3243–7. - PubMed
-
- Smith SC, Jr, Milani RV, Arnett DK, et al. Atherosclerotic Vascular Disease Conference: Writing Group II: risk factors. Circulation. 2004;109:2613–6. - PubMed
-
- Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–43. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
